J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 545, Number 2, 355-373, December 1, 2002 DOI: 10.1113/jphysiol.2002.032151
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
545/2/355    most recent
2002.032151v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Q.
Right arrow Articles by Doupnik, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Q.
Right arrow Articles by Doupnik, C. A.

Journal of Physiology (2002), 545.2, pp. 355-373
© Copyright 2002 The Physiological Society
DOI: 10.1113/jphysiol.2002.032151

Gating properties of GIRK channels activated by Galphao- and Galphai-coupled muscarinic m2 receptors in Xenopus oocytes: the role of receptor precoupling in RGS modulation

Qingli Zhang, Mary A. Pacheco* and Craig A. Doupnik

Department of Physiology and Biophysics and *Department of Pharmacology and Therapeutics, University of South Florida College of Medicine, Tampa, Florida 33612-4799, USA

  ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

'Regulators of G protein Signalling' (RGSs) accelerate the activation and deactivation kinetics of G protein-gated inwardly rectifying K+ (GIRK) channels. In an apparent paradox, RGSs do not reduce steady-state GIRK current amplitudes as expected from the accelerated rate of deactivation when reconstituted in Xenopus oocytes. We present evidence here that this kinetic anomaly is dependent on the degree of G protein-coupled receptor (GPCR) precoupling, which varies with different Galphai/o-RGS complexes. The gating properties of GIRK channels (Kir3.1/Kir3.2a) activated by muscarinic m2 receptors at varying levels of G protein expression were examined with or without the co-expression of either RGS4 or RGS7 in Xenopus oocytes. Different levels of specific m2 receptor-Galpha coupling were established by uncoupling endogenous pertussis toxin (PTX)-sensitive Galphai/o subunits with PTX, while expressing varying amounts of a single PTX-insensitive subunit (Galphai1(C351G), Galphai2(C352G), Galphai3(C351G), GalphaoA(C351G), or GalphaoB(C351G)). Co-expression of each of the PTX-insensitive Galphai/o subunits rescued acetylcholine (ACh)-elicited GIRK currents (IK,ACh) in a concentration-dependent manner, with Galphao isoforms being more effective than Galphai isoforms. Receptor-independent 'basal' GIRK currents (IK,basal) were reduced with increasing expression of PTX-insensitive Galpha subunits and were accompanied by a parallel rise in IK,ACh. These effects together are indicative of increased Gbetagamma scavenging by the expressed Galpha subunit and the subsequent formation of functionally coupled m2 receptor-G protein heterotrimers (Galpha(GDP)betagamma). Co-expression of RGS4 accelerated all the PTX-insensitive Galphai/o-coupled GIRK currents to a similar extent, yet reduced IK,ACh amplitudes 60-90 % under conditions of low Galphai/o coupling. Kinetic analysis indicated the RGS4-dependent reduction in steady-state GIRK current was fully explained by the accelerated deactivation rate. Thus kinetic inconsistencies associated with RGS4-accelerated GIRK currents occur at a critical threshold of G protein coupling. In contrast to RGS4, RGS7 selectively accelerated Galphao-coupled GIRK currents. Co-expression of Gbeta5, in addition to enhancing the kinetic effects of RGS7, caused a significant reduction (70-85 %) in steady-state GIRK currents indicating RGS7-Gbeta5 complexes disrupt Galphao coupling. Altogether these results provide further evidence for a GPCR-Galphabetagamma-GIRK signalling complex that is revealed by the modulatory affects of RGS proteins on GIRK channel gating. Our functional experiments demonstrate that the formation of this signalling complex is markedly dependent on the concentration and composition of G protein-RGS complexes.

(Resubmitted 6 September 2002; accepted 16 September 2002; first published online 4 October 2002)
Corresponding author C. A. Doupnik: Department of Physiology and Biophysics, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd/MDC 8, Tampa, FL 33612-4799, USA. Email: cdoupnik{at}hsc.usf.edu

  INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

G protein-gated inwardly rectifying K+ (GIRK) channels mediate slow inhibitory post-synaptic potentials (sIPSPs) in the central and peripheral nervous system and are activated by a variety of G protein-coupled receptors (GPCRs) that selectively interact with pertussis toxin (PTX)-sensitive Galphai/o proteins (for recent reviews see (Dascal, 1997; Yamada et al. 1998; Mark & Herlitze, 2000). Both the amplitude and the distinguishing slow time course for GIRK-mediated sIPSPs are inherently coupled to the kinetics of the G protein activation-deactivation cycle. The time course for GIRK channel activation is dependent on the receptor catalysed production of free Gbetagamma dimers that interact directly with the channel and increase open probability (Logothetis et al. 1987; Krapivinsky et al. 1995). Deactivation of GIRK currents is determined by the reaction rate for Gbetagamma sequestration, a process rate limited by the GTPase activity of associated Galphai/o proteins, Galpha(GTP) right Galpha(GDP), with a rate constant for GTP hydrolysis of kGTPase (Breitwieser & Szabo, 1988).

Given the large diversity and ubiquitous expression of heterotrimeric G proteins (Simon et al. 1991), several studies have begun investigating whether functional differences exist among the various Galphabetagamma subunits that may participate in GPCR right GIRK channel signalling (5 Galphai/o isoforms, 5 Gbeta genes, and 12 Ggamma genes) (Lledo et al. 1992; Wickman et al. 1994; Schreibmayer et al. 1996; Sowell et al. 1997; Takano et al. 1997; Valenzuela et al. 1997; Fernandez-Fernandez et al. 1999; Greif et al. 2000; Leaney et al. 2000; Leaney & Tinker, 2000; Lei et al. 2000; Blake et al. 2001; Fernandez-Fernandez et al. 2001). Adding to this molecular complexity is the recently identified 'Regulators of G protein Signalling' (RGSs) that accelerate the termination of G protein signalling by increasing kGTPase through a direct interaction with Galpha subunits (for recent reviews see De Vries et al. 2000; Ross & Wilkie, 2000). Several RGS proteins, of which there are now more than 20 mammalian genes identified, are capable of accelerating receptor-dependent GIRK activation and deactivation kinetics in heterologous expression systems (Doupnik et al. 1997; Saitoh et al. 1997; Granneman et al. 1998; Herlitze et al. 1999; Saitoh et al. 1999; Kovoor et al. 2000; Burgon et al. 2001). RGS-accelerated GIRK currents more closely resemble the properties of neuronal and cardiac GIRK currents, indicating native RGS proteins are likely to be important determinants of GIRK-mediated synaptic signalling.

Initial studies of RGS-accelerated GIRK channel kinetics revealed an apparent paradox where the RGS-accelerated activation phase, an expected consequence of accelerated deactivation according to standard kinetic concepts, was not accompanied with a reduction in steady-state current amplitude (Doupnik et al. 1997; Saitoh et al. 1997). These findings suggested that RGS proteins have actions on GPCR right GIRK signalling beyond the well-established GTPase-activating function of the RGS domain on Galpha(GTP) subunits (Zerangue & Jan, 1998). To further explore the effects of RGS proteins on receptor-dependent GIRK channel gating, we examined the actions of two distinct RGS proteins (RGS4 and RGS7) on GIRK channels (Kir3.1/Kir3.2a heteromers) activated by muscarinic m2 receptors coupled to varying concentrations and compositions of Galphai/obetagamma heterotrimers in Xenopus oocytes. Muscarinic m2 receptor-Galphabetagamma-GIRK channel coupling was established by expressing varying levels of PTX-insensitive Galphai/o subunits (Wise et al. 1997) while uncoupling oocyte Galphai/o subunits (xGalphai/o) with PTX. Our findings indicate that GPCR-G protein-RGS-GIRK precoupling is a critical determinant in the anomalous channel gating, and is dependent on the concentration and composition of Galphai/o-RGS proteins.

  METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Isolation of Xenopus oocytes

All procedures for the use and handling of Xenopus laevis (Xenopus One, Ann Arbor, MI, USA) were approved by the University of South Florida Institutional Animal Care and Use Committee in accordance with NIH guidelines. Oocytes were isolated from ovarian tissue surgically removed during hypothermia and 0.2% tricaine (MS-222)-induced anaesthesia. After recovery from anaesthesia, frogs were returned to their tanks in the institutional animal housing facility where they were monitored daily. Frogs were killed after a second procedure by exsanguination while under anaesthesia. The time between surgeries was 1-3 weeks.

The oocytes were enzymatically dissociated by a 50 min collagenase A (Boehringer Mannheim) digestion (1.8 %) at room temperature on a rocker platform in Ca2+-free oocyte Ringer (OR) solution. The OR solution was composed of 82.5 mM NaCl, 2.5 mM KCl, 1.0 mM CaCl2, 1.0 mM MgCl2, 1.0 mM NaHPO4 and 5.0 mM Hepes, at pH 7.5 (NaOH). Isolated stage V-VI oocytes were then maintained in oocyte culture medium (OCM) at 19 °C in 35 mm dishes on an orbital shaker. OCM was composed of OR solution containing 2.5 mM sodium pyruvate and 5 % heat-inactivated horse serum. OCM was changed 1-2 times daily.

Heterologous expression in Xenopus oocytes

Linearized cDNA-containing vectors (Table 1) were used to transcribe cRNA in vitro using the appropriate RNA polymerase (T7 or T3) as described by the manufacturer (mMessage mMachine, Ambion, Austin, TX, USA). Concentrations and quality of the cRNAs were determined by spectrophotometric absorbance at 260 nm and denatured (formaldehyde) agarose gel electrophoresis. On the first day after enzymatic isolation (Day 1), oocytes were injected with a mixture of cRNAs dissolved in DEPC-treated H2O at a final injection volume of 50 nl (Nanoliter2000, World Precision Instruments). All oocytes were injected with cRNAs for Kir3.1 (0.5 ng), Kir3.2a (0.5 ng), and the m2 receptor (0.5 ng). The amounts of other cRNAs, including PTX-insensitive Galpha subunits and RGSs, were varied as described in the Results section. The PTX-insensitive Galpha cDNAs were all constructed by PCR (kindly provided by Stephen Ikeda, NIAAA, Bethesda, MD, USA), having a 5' Kozak sequence followed by the Galpha coding region containing the C-terminal CrightG mutation. The 5' and 3' untranslated regions of the Galpha cDNAs were not included in the constructs, and therefore ribosomal binding and translation initiation of each PTX-insensitive Galpha cRNA are expected to be equivalent.

tab1

Two methods were used to inactivate endogenous oocyte Galphai/o subunits by PTX-mediated ADP ribosylation. Initially we injected the PTX holotoxin (containing S1, S2, S3, S4 and S5 subunits from Bordetella pertussis, Sigma-Aldrich Chemical) at 1 ng/oocyte on Day 2 of culture (1 day after cRNA injection), and then recorded GIRK currents on Day 4. This method inhibited > 80 % of the m2 receptor-activated GIRK currents coupled to endogenous Galphai/o subunits that was determined for each batch of oocytes to monitor the efficiency of endogenous G protein uncoupling. In subsequent experiments we included cRNA (1 ng/oocyte) encoding the catalytically active PTX-S1 subunit (kindly provided by Eitan Reuveny, Weizmann Institute, Israel) with the mixture of other cRNAs in the initial Day 1 cRNA injection (Vivaudou et al. 1997). This produced a much more effective > 95 % uncoupling of endogenous Galphai/o subunits which also was determined for each batch of oocytes tested.

Electrophysiological recordings

Macroscopic GIRK currents were measured using a two-electrode voltage clamp amplifier (GeneClamp 500, Axon Instruments) and standard recording techniques (Stuhmer & Parekh, 1995). Electrodes were fabricated from borosilicate glass tubes (1.5 outside diameter, 0.86 inside diameter, GC150F-10, Warner Instruments) by a programmable microelectrode puller (P-97, Sutter Instruments). Electrodes were filled with 3 M KCl and had tip resistances of 0.8-1.0 MOmega. Membrane currents from voltage clamped oocytes were digitized using a Digidata 1200 acquisition system (Axon Instruments) and a Dell PC computer running pCLAMP 7.0 software (Axon Instruments).

Oocytes were placed in a recording chamber continuously perfused with a minimal Ringer solution composed of 98 mM NaCl, 1 mM MgCl2 and 5 mM Hepes at pH 7.5 (NaOH). After electrode impalement and clamping the membrane potential to -80 mV, the perfusion solution was changed to a high K+ solution composed of 20 mM KCl, 78 mM NaCl, 1 mM MgCl2, and 5 mM Hepes at pH 7.5 (NaOH). The resulting increase in inward current represents a 'basal' K+ current (IK,basal) that is due primarily to receptor-independent GIRK channel activity (Dascal et al. 1993). Rapid application and washout of acetylcholine (ACh, Sigma-Aldrich Chemical) produced the receptor-dependent GIRK current (IK,ACh), and was performed with a computer controlled perfusion system (SF-77B, Warner Instruments) that rapidly switched the position of two perfusion barrels (barrel A and barrel B) located next to the oocyte. The perfusion barrels contained high K+ solution (barrel A) and high K+ solution plus ACh (barrel B). For barrel B, a range of ACh concentrations was tested for each oocyte via a manifold that connected multiple reservoirs containing different ACh concentrations. Flow through the perfusion barrels was gravity driven, and the time constant for solution exchange was ~1 s as determined by the time course change in receptor-independent GIRK current with switching between 20 and 40 mM external K+. All recordings were performed at room temperature (21-23 °C).

Electrophysiological data analysis

Time-dependent GIRK current kinetics were analysed using non-linear curve fitting software that fit single exponential functions to derive activation time constants (tauact) and deactivation time constants (taudeact) (Clampfit software, Axon Instruments). Dose-response relations were analysed by fitting peak GIRK current amplitudes with the following Hill function:

eqt1

where the effective concentration producing a 50 % response (EC50) and Hill coefficient value (nH) were derived from the best fit (Origin 6.0 software, OriginLab Corp., Northampton, MA, USA). In some cases where the GIRK current did not reach a steady-state level at the end of the agonist application period (i.e. low agonist concentrations), the steady-state current amplitude was estimated by the fit of the activation time course to an extrapolated steady-state value.

Statistical comparisons between the various experimental groups were performed by one-way ANOVA where P < 0.05 was considered significant. Experiments were each replicated in oocytes from 2-4 separate batches (dissections) of oocytes.

Radiolabelling, immunoprecipitation and Western blotting of Galphai/o proteins

To compare the relative expression levels of PTX-insensitive Galphai/o proteins, [35S]Met/Cys (Pro-mix, Amersham Pharmacia, Piscataway, NJ, USA) was added to OCM (0.5 mCi ml-1) 1-2 h after cRNA injection to initiate radiolabelling of proteins. Fresh OCM containing [35S]Met/Cys was added on a daily basis, and 3 days after cRNA injection ~20 oocytes from each experimental group were washed with label-free OR solution and homogenized in the following lysis buffer (150 mM NaCl, 50 mM Tris-Cl, 1 mM dithiothreitol (DTT), 1.0 % Trition X-100, and protease inhibitor cocktail (Boehringer Mannheim), pH 7.5) at 50 µl/oocyte. The oocyte lysate was then centrifuged at 10 000 g for 10 min to clear insoluble debris.

Galphai/o subunits were immunoprecipitated from oocyte lysates using a rabbit polyclonal antibody that recognizes an internal epitope (GAGESGKSTIVKQMK) identical among Galphai/o isoforms (SA-126, BIOMOL Research Laboratories, Plymouth Meeting, PA, USA). To expose the internal epitope, the supernatant from the equivalent of five oocytes (250 µl) was diluted in SDS denaturing buffer (50 mM NaPO4, 2 mM EDTA, 1 mM DTT, 0.5 % SDS, pH 8.0) and boiled for 3 min. The denaturated supernatants were then diluted and solubilized further in RIPA buffer (150 mM NaCl, 50 mM NaPO4, 2 mM EDTA, 1 mM DTT, 1.0 % Triton X-100, 1.0 % deoxycholate, 0.5 % SDS, pH 7.2). Denatured oocyte lysates (~700 µl each) were then pre-cleared with 10 µl of non-immune rabbit serum (1 h incubation at 4 °C) and 20 µl Protein A/G-agarose beads (Santa Cruz Biotechnology, Inc.). Galphai/o proteins were immunoprecipitated in an overnight incubation at 4 °C using the SA-126 antibody precoupled to Protein A/G-agarose beads. We initially tested different amounts of oocyte lysate (0.5, 1, 2 and 4 oocytes) with a fixed amount of SA-126 antibody (2 µl) and Protein A/G-agarose (20 µl) to establish non-saturating binding conditions, which was determined to be <= 1 oocyte. All immunoprecipitations were then performed using the lysate equivalent of a single oocyte. At the end of the overnight incubation period, beads were washed three times with lysis buffer and the immunoprecipitated proteins eluted by boiling in 40 µl of SDS loading buffer (62.5 mM Tris-Cl pH 6.8, 10 % glycerol, 5 % beta-mercaptoethanol, 2 % SDS, 0.05 % bromophenol blue).

Immunoprecipitated proteins were separated by SDS-polyacrylamide (8 %) gel electrophoresis and then transferred to a polyvinylidene difluoride (PVDF) membrane by overnight electrophoretic transfer at 4 °C. 35S-labelled proteins were resolved by autoradiography. Western blot analysis was performed using a polyclonal goat antibody that recognizes a conserved region in Galphai/o/t/z proteins (sc-12798, Santa Cruz Biotechnology). A ~41 kDa band corresponding to Galphai/o proteins was readily detected by an HRP-conjugated donkey anti-goat secondary antibody (sc-2033, Santa Cruz Biotechnology) and enhanced chemiluminescence. Relative radiolabelling and Galphai/o protein levels were quantified by densitometric analysis (GS-700 Imaging Densitometer, Bio-Rad) of the 41 kDa band following normalization to a sample control.

  RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Conferring specific m2 receptor-Galpha-coupling in Xenopus oocytes

To assess the properties of receptor-dependent GIRK channel gating elicited by specific Galpha-coupled m2 receptors, oocyte Galphai/o subunits were inactivated by PTX while expressing one of five different PTX-insensitive Galphai/o subunits (Galphai1(C351G), Galphai2(C352G), Galphai3(C351G), GalphaoA(C351G), or GalphaoB(C351G)) (Wise et al. 1997). As reported previously, expression of PTX-S1 blocked > 95 % of IK,ACh and effectively abolished endogenous Galphai/o protein coupling (Vivaudou et al. 1997). Shown in Fig. 1, co-expression of Galphai2(C352G) rescued the m2 receptor-coupled GIRK currents and was dependent on the level of Galphai2(C352G) expression (Fig. 1B). Injection of 5 or 10 ng of Galphai2(C352G) cRNA per oocyte produced ACh-evoked GIRK currents that were ~50 and 95 %, respectively, the peak amplitude of GIRK currents recorded from paired oocytes utilizing endogenous Galphai/o subunits (i.e. no PTX-S1 or Galphai2(C352G) cRNA). The Galphai2(C352G)-dependent GIRK currents represent channels activated by m2 receptors coupled specifically to Galphai2(C352G) subunits and endogenous Gbetagamma dimers. Galphai2(C352G)-dependent IK,ACh was also associated with a parallel 50-60 % decrease in IK,basal (Fig. 1D). The reduction in IK,basal by Galphai2(C352G) is likely due to the sequestration of free Gbetagamma dimers that mediate receptor-independent basal GIRK channel activity (Lim et al. 1995; Vivaudou et al. 1997; Jeong & Ikeda, 1999).

F1 View larger version
[in this window]
[in a new window]

Figure 1. Specific coupling of Galphai2(C352G) to m2 receptors and GIRK channel activation in Xenopus oocytes

A, typical ACh-evoked GIRK currents (IK,ACh) recorded from different oocytes from three separate experimental groups. Upper traces: IK,ACh from a 'control' oocyte expressing muscarinic m2 receptors and Kir3.1/Kir3.2a channel subunits, utilizing endogenous Galphai/o proteins for receptor activation. Middle trace: co-expression of PTX-S1 (1 ng cRNA/oocyte) effectively uncouples ACh-evoked GIRK currents utilizing oocyte Galphai/o proteins. Lower traces: expression of the PTX-insensitive Galphai2(C352G) subunit (5 ng cRNA) with PTX-S1 rescues m2 receptor-coupled GIRK currents. All GIRK currents were elicited by a 25 s application of different concentrations of ACh as indicated. Bottom traces: superimposed IK,ACh elicited by 1 µM ACh from the control oocyte (grey trace) and the Galphai2(C352G)-coupled oocyte (black trace). Peak amplitudes are normalized to illustrate the kinetic differences in the activation and deactivation time courses. B, ACh dose-response relations for GIRK activation via m2 receptors coupled to oocyte Galphai/o subunits (circle, control) and Galphai2(C352G) at different levels of expression (filled square 1 ng, filled up triangle 5 ng, and filled circle 10 ng cRNA/oocyte). C, ACh-dose-response curves from B normalized to maximal IK,ACh. D, comparison of receptor-independent basal GIRK currents (IK,basal) with varying levels of Galphai2(C352G) expression. IK,basal is expressed as the percentage change in the 'control group' mean value determined for each batch of oocytes. E, activation time constants (tauact) and F, deactivation time constants (taudeact) for GIRK currents coupled to varying levels of Galphai2(C352G) expression and different concentrations of ACh. circle control; filled up triangle 5 ng; and filled circle 10 ng of Galphai2(C352G) cRNA/oocyte. Data in B-F represent the means ± S.E.M. from at least 3 batches of oocytes with the number of oocytes indicated. * P < 0.05.

ACh dose-response curves derived from oocytes expressing different levels of Galphai2(C352G) were not significantly different with respect to their EC50 value as shown in Fig. 1C, and this is consistent with previous studies where EC50 values were shown to be relatively unaffected by overexpressed Galpha subunits, but most sensitive to levels of GPCR expression (Henry et al. 1995). Since the same amount of m2 receptor cRNA was injected for all experimental groups (0.5 ng cRNA/oocyte), m2 receptor protein levels were assumed to be roughly equivalent across groups and this was supported by the equivalent EC50 values with varying Galphai2(C352G) expression levels. The ACh dose-response curves for Galphai2(C352G)-coupled m2 receptors, however, were notably shifted rightward compared to the ACh dose-response relation from m2 receptor coupling to endogenous Galphai/o subunits (Fig. 1B). The higher EC50 value for Galphai2(C352G) versus endogenous Galphai/o-coupled receptors may be attributable to the mixed coupling of oocyte Galphao and Galphai subunits, and/or a lower level of m2 receptors precoupled to heterotrimeric G proteins (Shea & Linderman, 1997; Shea et al. 2000) (see Results below and Discussion).

One readily apparent feature of the m2 receptor- Galphai2(C352G)-coupled GIRK current was the significantly slower activation and deactivation kinetics as compared to GIRK currents coupled to endogenous xGalphai/o subunits (Fig. 1A). The time constants for IK,ACh activation and deactivation over a range of ACh concentrations are shown in Fig. 1E and F. The slower kinetics for m2 receptor-Galphai2(C352G)-coupled GIRK currents were not attributable to the level of Galphai2(C352G) expression since increasing amounts of Galphai2(C352G) cRNA, which nearly doubled maximal IK,ACh amplitudes, did not result in significantly different GIRK activation or deactivation time constants. The slower GIRK gating properties may be caused by altered coupling properties of the CrightG mutated Galphai2 subunit, or alternatively the faster properties in the absence of overexpressed Galpha subunits may reflect the influence of endogenous RGS proteins (Saitoh et al. 2000).

GIRK channel gating properties via Galphao- and Galphai-coupled m2 receptors

The gating properties of GIRK currents elicited by m2 receptors coupled to each of the PTX-insensitive Galphai/o subunits are shown in Fig. 2. Since there were no noticeable differences in GIRK current kinetics at different levels of Galphai2(C352G) expression, comparisons between the five different Galphai/o isoforms were initially made using 5 ng cRNA/oocyte for each Galpha isoform. The three Galphai isoforms (Galphai1(C351G), Galphai2(C352G) and Galphai3(C351G)) each produced ACh-elicited GIRK currents that were indistinguishable from each other with regard to the five parameters analysed (maximal IK,ACh, IK,basal, EC50, tauact and taudeact) (Fig. 2). GalphaoA(C351G) and GalphaoB(C351G) also produced equivalent GIRK responses but were distinct from Galphai-coupled GIRK currents in several respects. First, Galphao-coupled GIRK currents were significantly larger than Galphai-coupled currents, with maximal IK,ACh amplitudes being ~2-fold greater (Fig. 2B). Second, expression of GalphaoA(C351G) and GalphaoB(C351G) more prominently inhibited IK,basal compared to Galphai1(C351G), Galphai2(C352G), or Galphai3(C351G) (Fig. 2B). Third, the EC50 values for GalphaoA(C351G) and GalphaoB(C351G) were more similar to the EC50 values with endogenous xGalphai/o coupling than with Galphai1(C351G), Galphai2(C352G), or Galphai3(C351G) (Fig. 2C). And finally, the activation of Galphao-coupled GIRK currents was faster compared to Galphai-coupled currents and had a more prominent sigmoidal time course (Fig. 2D). The deactivation time course for IK,ACh was not significantly different among all five Galphai/o isoforms (Fig. 2D).

F2 View larger version
[in this window]
[in a new window]

Figure 2. Properties of ACh-evoked GIRK currents activated by m2 receptors coupled to five different Galphai/o subunits

A, typical ACh-evoked GIRK currents for each PTX-insensitive Galphai/o subunit examined (Galphai1(C351G), Galphai2(C352G), Galphai3(C351G), GalphaoA(C351G) and GalphaoB(C351G)). Currents were elicited by a 25 s application of 1 µM ACh. B, maximal amplitude of receptor-dependent GIRK currents (IK,ACh, grey bars) and receptor-independent GIRK currents (IK,basal, black bars) for each expressed PTX-insensitive Galpha subunit (Galpha*). Galpha* expression was produced by 5 ng cRNA/oocyte. Maximal IK,ACh responses are to 10 µM ACh. C, EC50 values for control (open bar) and each PTX-insensitive Galpha* subunit, derived from ACh dose-response relations for IK,ACh activation. D, activation (black bars) and deactivation time constants (grey bars) derived from exponential fits of the IK,ACh time course in response to rapid ACh application and washout. For B-D, data represent the means + S.E.M. from at least 3 batches of oocytes with the number of oocytes indicated (*P < 0.05). In B and D, statistical comparisons were with Galphai1(C351G), and in C comparisons were with oocyte Galphai/o coupling (open bar).

The differences between Galphai and Galphao-coupled GIRK currents were not attributable to cDNA/vector construction (i.e. untranslated regions), cRNA quantification, or batch-to-batch oocyte variability (see Methods). Several factors could conceivably contribute to these differences and include (1) differences in Galphai/o biosynthesis or degradation (Li et al. 1996), (2) preferential Galphao coupling to m2 receptors (Leaney & Tinker, 2000), (3) preferential Galphao association with oocyte Gbetagamma subunits (Fernandez-Fernandez et al. 2001), and (4) different Galphai/o subcellular distributions (Devic et al. 1996).

Biochemical analysis of PTX-insensitive Galphai/oprotein expression levels

To determine whether PTX-insensitive Galphai/o subunits are differentially expressed following cRNA injection (5 ng cRNA/oocyte, as in Fig. 2), Galphai/o proteins were immunoprecipitated from oocytes following metabolic labelling with [35S]Met/Cys. The PTX-insensitive Galphai/o proteins each contain an equivalent number of Met/Cys sites (19) for potential radiolabelling. As shown in Fig. 3A, a prominent ~41 kDa band that corresponds to Galphai/o proteins was radiolabelled in each experimental group. A significant portion represents radiolabelling of endogenous xGalphai/o proteins over the 3 day incubation period as indicated by the oocyte groups that were not injected with PTX-insensitive Galphai/o cRNA. Quantitative comparisons of the 35S-labelled 41 kDa band via densitometric analysis indicate a small 10-20 % elevation in oocytes injected with PTX-insensitive Galphai/o cRNAs (Fig. 3B). The observed changes in 35S labelling were also paralleled by densitometric changes in the bands detected by Western blot analysis (Fig. 3B). Since the peak IK,ACh amplitudes for Galphao-coupled m2 receptors were ~2 times higher compared to Galphai-coupled m2 receptors under equivalent expression conditions (cf. Fig. 2B), the ~2-fold difference in GalphaoB(C351G) versus Galphai2(C352G) or Galphai3(C351G) protein expression could potentially account for the differences in m2 receptor-GIRK channel coupling. GalphaoA(C351G)-elevated protein levels, however, were similar to Galphai2(C352G) and Galphai3(C351G) levels (Fig. 3B), and resolving small expression changes was clearly limited by the biochemical approach. Thus despite equivalent cRNA injections (5 ng cRNA/oocyte each), differences in Galphai/o biosynthesis and/or degradation may result in different steady-state Galphai/o protein levels that account for the distinct gating properties of Galphao- versus Galphai-coupled GIRK currents.

F3 View larger version
[in this window]
[in a new window]

Figure 3. Biochemical analysis of PTX-insensitive Galphai/o protein levels in Xenopus oocytes

A, radiolabelling (upper panel) and Western blot analysis (lower panel) of oocytes injected with cRNAs encoding five different PTX-insensitive Galphai/o subunits (ast) as described in Methods and Fig. 2. Oocytes were incubated for 3 days in OCM containing 0.5 mCi ml-1 [35S]Met/Cys. All groups were injected with cRNAs for the m2 receptor and GIRK channel subunits Kir3.1 and Kir3.2a (0.5 ng each/oocyte). PTX-insensitive Galphai/o cRNAs (5 ng/oocyte) were injected with PTX-S1 cRNA (1 ng/oocyte). Both endogenous and heterologously expressed Galpha proteins were immunoprecipitated from the lysate equivalent of one oocyte using a 'common' Galpha antibody, then separated by SDS-PAGE and transferred to a PVDF membrane for autoradiography and Western blotting. The 41 kDa band corresponding to Galphai/o proteins is indicated. B, quantitative analysis of Galphai/o proteins detected by radiolabelling and Western blot analysis. The 41 kDa band from the control group (no PTX-insensitive Galphai/o cRNA) served as an internal reference and was used to normalize the band intensity among the different experimental groups in each autoradiogram and Western blot. The Western blot results are the means + S.E.M. obtained from 3 independent experiments (separate batches of injected oocytes that were immunoprecipitated and immunostained as described in Methods). The radiolabelling data are the means + S.E.M. obtained from 2 of the Western blot experiments. * P < 0.05.

The GIRK activation time course is dependent on free Gbetagamma levels

A sigmoidal time course for GIRK activation, as observed with Galphao expression (Fig. 2), is well documented in cardiomyocytes and neurons and indicative of a multi-step process in channel opening (Inomata et al. 1989; Sodickson & Bean, 1996). Tetrameric GIRK channels can bind up to four Gbetagamma dimers, and functional studies indicate at least two Gbetagamma dimers are necessary for channel opening (Nemec et al. 1999; Corey & Clapham, 2001). We questioned whether the sigmoidal GIRK activation time course via Galphao-coupled receptors was a consequence of a markedly reduced free Gbetagamma concentration as indicated by the low IK,basal level. As illustrated in Fig. 4A, conditions favouring high free Gbetagamma concentrations (high IK,basal) would yield a single exponential time course for receptor activation, where the binding of a single Gbetagamma dimer leads to channel opening. At low free Gbetagamma concentrations (i.e. low IK,basal), GIRK channels would instead be occupied by fewer Gbetagamma dimers (less than 3 Gbetagamma) and require multiple Gbetagamma binding events during receptor activation (2-4 Gbetagamma). According to this hypothesis, reducing Galphao expression levels should increase IK,basal and promote a single exponential time course for IK,ACh activation.

F4 View larger version
[in this window]
[in a new window]

Figure 4. Activation kinetics of Galphao-coupled GIRK currents at different levels of GalphaoB(C352G) expression

A, kinetic scheme for GIRK channel activation via Gbetagamma binding to each of the four GIRK channel subunits. Four closed states are depicted with 0 to 3 bound Gbetagamma dimers. Channel opening (O) occurs with the binding of 4 Gbetagamma dimers. The level of free Gbetagamma dimers then determines the channel-bound state that precedes receptor activation. B, left panel: ACh-evoked GIRK currents from oocytes injected with either 1 or 5 ng GalphaoB(C351G) cRNA. Right panel: the activation phase for the 1 µM ACh-evoked GIRK currents are displayed at higher temporal resolution. Red lines represent non-linear fits to the data. A single exponential function (G1) best described the IK,ACh time course with low GalphaoB(C351G) expression (1 ng RNA/oocyte), having a time constant of 8.1 s. A third-order exponential function (G3) best described the activation time course at high GalphaoB(C351G) expression (5 ng RNA/oocyte), having a time constant of 4.4 s. C, ACh dose-response curves for m2 receptor-activated GIRK currents from control oocytes (circle) and oocytes expressing GalphaoB(C351G) at two different levels (filled square 1 ng and filled up triangle 5 ng cRNA/oocyte). D, effects of GalphaoB(C351G) expression levels on receptor-independent GIRK channel activity (IK,basal). The open bar is from control oocyte responses, and black bars are from oocytes injected with varying amount of GalphaoB(C351G) cRNA and PTX-S1 cRNA (1 ng/oocyte). Data represent the means + S.E.M. from 4 batches of oocytes with the number of oocytes indicated.

To test this, we compared the activation time course of IK,ACh at two different levels of GalphaoB(C351G) expression (Fig. 4). As expected, lower expression of GalphaoB(C351G) (1 ng GalphaoB(C351G) cRNA/oocyte) produced smaller IK,ACh amplitudes compared to high GalphaoB(C351G) expression, and had significantly higher receptor-independent basal GIRK activity (Fig. 4C and D). The activation time course for IK,ACh was clearly affected by the level of GalphaoB(C351G) expression and was consistent with the gating scheme shown in Fig. 4A. Low GalphaoB(C351G) expression yielded GIRK currents whose activation time course was well described by a single exponential function. In contrast, high GalphaoB(C351G) expression yielded GIRK currents whose activation time course had a significant delay and were best described by a 3rd order exponential function, suggesting the binding of three Gbetagamma subunits in receptor-dependent GIRK activation (see Fig. 4A). The tauact was smaller for high GalphaoB(C351G) expression versus low GalphaoB(C351G) expression, and single exponential fits to the rising phase of the sigmoidal time course underestimate the activation rate constant (1/tauact) under these conditions. Comparisons of taudeact and EC50 values from ACh dose-response curves indicated the these properties were not significantly affected by these levels of GalphaoB(C351G) expression (data not shown).

RGS4 reduces GIRK currents at low Galphai/o coupling levels

We next evaluated the effects of RGS4 at saturating expression levels (10 ng RGS4 cRNA/oocyte; Doupnik et al. 1997; Keren-Raifman et al. 2001) on both Galphao- and Galphai-coupled m2 receptors as described in Fig. 2. As shown in Fig. 5, RGS4 accelerated the receptor-dependent GIRK activation and deactivation kinetics for each Galphai/o isoform, consistent with the non-selective GTPase activating properties of RGS4 on Galphai/o subunits in vitro (Berman et al. 1996; Watson et al. 1996). Interestingly, however, RGS4 suppressed 60-70 % of the IK,ACh amplitude for Galphai-coupled m2 receptors, yet had no effect on the peak IK,ACh amplitude of Galphao-coupled receptors. RGS4 did not significantly affect the EC50 for channel activation via Galphai-coupled receptors, but did cause a small shift the EC50 value for GalphaoA(C351G)-coupled GIRK currents towards a higher ACh concentration, which more closely corresponded to the EC50 values of Galphai-coupled GIRK currents (Fig. 5F). Kinetic analysis indicated the RGS4-mediated reduction in Galphai-coupled IK,ACh (Fig. 5E) was fully explained by the RGS4-accelerated GIRK deactivation rate (see Table 2 and Discussion).

tab2

F5 View larger version
[in this window]
[in a new window]

Figure 5. Effects of RGS4 on GIRK currents coupled to specific PTX-insensitive Galphai/o subunits

All data are from oocytes injected with 5 ng Galpha* cRNA/oocyte, with or without 10 ng RGS4 cRNA/oocyte. Endogenous PTX-sensitive Galphai/o subunits were inactivated by either PTX injection or PTX-S1 expression as described in Methods. Data are means and S.E.M.; * P < 0.05. A, representative ACh-evoked GIRK currents from oocytes expressing either Galphai2(C352G) (upper traces) or GalphaoA(C351G) (lower traces) with and without RGS4 coexpression. Scale bars indicate 1 µA and 10 s. B, ACh dose-response relations for m2 receptor-coupled GIRK currents from oocytes expressing Galphai2(C352G) in the absence (filled up triangle) or presence of RGS4 (down triangle). C, IK,ACh activation time constants (tauact) from oocytes expressing PTX-insensitive Galphai/o subunits alone (black bars) or with co-expressed RGS4 (grey bars). Time constants were derived from a single exponential fit to the rising phase of IK,ACh elicited by 1 µM ACh. D, deactivation time constants (taudeact) derived from ACh-elicited GIRK currents recorded from oocytes expressing PTX-insensitive Galphai/o subunits alone (black bars) or with co-expressed RGS4 (grey bars). Time constants were derived from a single exponential fit to the decay of IK,ACh after rapid washout of 1 µM ACh. E, effects of RGS4 on maximal IK,ACh responses elicited by m2 receptors coupled to PTX-insensitive Galphai/o subunits. IK,ACh amplitudes (10 µM ACh) from RGS4-expressing oocytes are expressed as a percentage of the mean IK,ACh amplitude from oocytes expressing the PTX-insensitive Galphai/o subunit alone (RGS-). F, effects of RGS4 on the EC50 for ACh activation of GIRK currents coupled to m2 receptors and PTX-insensitive Galphai/o subunits. Black bars are without RGS4 expression (-RGS4), grey bars are with RGS4 co-expression (+RGS4).

To determine whether the higher degree of Galphao versus Galphai coupling (cf. Fig. 2) could account for the RGS4-dependent effects on steady-state GIRK currents, we examined the effects of RGS4 at a lower level of GalphaoA expression (0.5 ng cRNA/oocyte). At low GalphaoA expression levels, RGS4 significantly reduced ~90 % of both IK,ACh (GalphaoA alone, 0.76 ± 0.11 µA, n = 17; GalphaoA + RGS4, 0.07 ± 0.03 µA, n = 9; P < 0.05) and IK,basal (GalphaoA alone, 2.34 ± 0.18 µA, n = 19; GalphaoA + RGS4, 0.25 ± 0.07 µA, n = 14; P < 0.05). Thus the effect of RGS4 on steady-state GIRK current amplitudes is dependent on the level of Galphai/o expression and GPCR precoupling. At high levels of m2 receptor-Galphao coupling (i.e. Fig. 5), RGS4 accelerates GIRK activation and deactivation without significantly reducing steady-state GIRK current amplitudes and resembles the effects of RGS4 with endogenous xGalphai/o coupling (Doupnik et al. 1997).

RGS7 selectively accelerates Galphao-coupled GIRK currents

RGS7 belongs to a distinct subfamily of RGS proteins that contain a Ggamma-like (GGL) domain that specifically binds Gbeta5 subunits (Snow et al. 1998; Sondek & Siderovski, 2001). RGS7 has relatively weak effects on GIRK current kinetics when expressed without Gbeta5 in Xenopus oocytes (Saitoh et al. 1999), but is significantly enhanced by Gbeta5 co-expression (Kovoor et al. 2000; Keren-Raifman et al. 2001). We examined whether RGS7 (10 ng cRNA/oocyte), with or without co-expressed Gbeta5 subunits, differentially affected Galphao- versus Galphai-coupled GIRK currents. In the absence of coexpressed Gbeta5, RGS7 preferentially accelerated Galphao-coupled GIRK currents having little effect on Galphai-coupled GIRK kinetics (Fig. 6), which is consistent with other studies indicating RGS7 selectively interacts with Galphao subunits (Posner et al. 1999; Lan et al. 2000; Rose et al. 2000). Interestingly, RGS7 acceleration of Galphao-coupled IK,ACh was greater than that caused by RGS4 (cf. Fig. 5C and D) and was evident for both the IK,ACh activation and deactivation time course as well as the desensitization rate. As observed with RGS4, RGS7 did not cause a significant reduction in the maximal Galphao-coupled GIRK current despite accelerating the GIRK channel gating kinetics (Fig. 6E), but did cause a small shift in the ACh dose-response curve (Fig. 6B and F). Yet in contrast to RGS4, RGS7 did not reduce steady-state GIRK currents when GalphaoA expression was markedly reduced (0.5 ng cRNA/oocyte): IK,basal (GalphaoA alone, 2.34 ± 0.18 µA, n = 19; GalphaoA + RGS7, 2.18 ± 0.20 µA, n = 18) and IK,ACh (GalphaoA alone, 0.76 ± 0.11 µA, n = 17; GalphaoA + RGS7, 1.25 ± 0.21 µA, n = 17).

F6 View larger version
[in this window]
[in a new window]

Figure 6. Effects of RGS7 on GIRK currents coupled to specific PTX-insensitive Galphai/o subunits

All data are from oocytes injected with 5 ng Galpha* cRNA/oocyte, with or without 10 ng RGS7 cRNA/oocyte. Endogenous PTX-sensitive Galphai/o subunits were inactivated by either PTX injection or PTX-S1 expression as described in Methods. Data are means and S.E.M.; * P < 0.05. A, representative ACh-evoked GIRK currents from oocytes expressing either Galphai2(C352G) (upper traces) or GalphaoA(C351G) (lower traces) with and without RGS7 coexpression. Scale bars indicate 1 µA and 10 s. B, ACh dose-response relations for m2 receptor-coupled GIRK currents from oocytes expressing Galphai2(C352G) in the absence (filled up triangle) or presence of RGS7 (down triangle). C, IK,ACh activation time constants (tauact) from oocytes expressing PTX-insensitive Galphai/o subunits alone (black bars) or with co-expressed RGS7 (grey bars). Time constants are from GIRK currents evoked by 1 µM ACh. D, deactivation time constants (taudeact) from ACh-elicited GIRK currents recorded from oocytes expressing PTX-insensitive Galphai/o subunits alone (black bars) or with co-expressed RGS7 (grey bars). Time constants were derived after rapid washout of 1 µM ACh. E, effects of RGS7 on maximal IK,ACh responses elicited by m2 receptors coupled to PTX-insensitive Galphai/o subunits. IK,ACh amplitudes (10 µM ACh) from RGS4-expressing oocytes as a percentage of the mean IK,ACh amplitude from oocytes expressing the PTX-insensitive Galphai/o subunit alone (no RGS7). F, effects of RGS7 on the EC50 for ACh activation of GIRK currents coupled to m2 receptors and PTX-insensitive Galphai/o subunits. Black bars are without RGS7 expression, grey bars are with RGS7 co-expression.

RGS7-Gbeta5 disrupts Galphao-coupled GIRK currents

Gbeta5 binds with high affinity to the GGL domain of RGS7, enhancing the GAP activity and protein stability of RGS7 (Levay et al. 1999; Kovoor et al. 2000; Keren-Raifman et al. 2001). We examined the effects of Gbeta5 expression on the RGS7- mediated regulation of both Galphao- and Galphai-coupled GIRK currents, with comparisons made using Gbeta1 as a negative control which does not bind to RGS7 (Levay et al. 1999; Kovoor et al. 2000). As shown in Fig. 7, co-expression of Gbeta5 with RGS7 caused a significant reduction (70-80 %) in Galphao-coupled GIRK current amplitudes, yet had no effect on Galphai-coupled currents. The lack of effect of Gbeta5 on Galphai-coupled GIRK currents indicates the level of Gbeta5 (or Gbeta5gamma formation) does not cause a direct inhibition of GIRK currents as observed in transfected HEK-293 cells (Lei et al. 2000). In addition to reducing Galphao-coupled GIRK currents, Gbeta5 enhanced the RGS7-accelerated GIRK kinetics consistent with RGS7-Gbeta5 complexes having greater GAP activity compared to RGS7 alone (Kovoor et al. 2000; Keren-Raifman et al. 2001). Thus the formation of RGS7-Gbeta5 complexes apparently disrupts Galphao coupling (either to m2 receptors and/or GIRK channels) and is supported by the effects of Gbeta5 on RGS7-Galphao interactions in vitro (Levay et al. 1999).

F7 View larger version
[in this window]
[in a new window]

Figure 7. Effects of Gbeta5 on RGS7-accelerated GIRK currents coupled to specific PTX-insensitive Galphai/o subunits

All data are from oocytes injected with 5 ng Galpha* cRNA/oocyte and 10 ng RGS7 cRNA/oocyte, with either 5 ng Gbeta5 cRNA/oocyte or 5 ng Gbeta1 cRNA/oocyte as a negative control. Oocytes also received Kir3.1 and Kir3.2a cRNA (0.5 ng/oocyte each), and m2 receptor cRNA (0.5 ng/oocyte), and endogenous PTX-sensitive Galphai/o subunits were inactivated by PTX-S1 expression (1.0 ng/oocyte). Data are means + S.E.M.; * P< 0.05. A, representative ACh-evoked GIRK currents from oocytes expressing RGS7 and Galphai2(C352G) with either Gbeta1 or Gbeta5 (upper traces), or GalphaoA(C351G) with either Gbeta1 or Gbeta5 (lower traces). Scale bars indicate 1 microA and 10 s. B, GIRK currents from A, normalized to peak amplitude and superimposed to highlight their temporal features (black traces, RGS7+Gbeta1; grey traces, RGS7+Gbeta5). C, Gbeta5 selectively suppresses RGS7/ Galphao-coupled GIRK currents. IK,ACh amplitudes are expressed as a percentage of the mean IK,ACh amplitude from oocytes expressing the negative control Gbeta1. D, GIRK activation time constants (tauact) derived from oocytes expressing different PTX-insensitive Galphai/o subunits with either RGS7 + Gbeta1 (black bars) or RGS7 + Gbeta5 (grey bars). Time constants were derived from a single exponential fit to the rising phase of IK,ACh elicited by 1 microM ACh. E, deactivation time constants (taudeact) derived from ACh-elicited GIRK currents as in D. Time constants were derived from a single exponential fit to the decay of IK,ACh after rapid washout of 1 microM ACh.

  DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

The goal of this study was to determine whether functional differences exist in the GPCR-dependent gating properties of GIRK channels coupled to specific Galphai/o subunits and RGS proteins. Our findings reveal that m2 receptors coupled to Galphai and Galphao subunits are differentially regulated by RGS4 and RGS7. A significant finding of our study is the identification of G protein coupling levels as a critical determinant in mediating the anomalous kinetic effects of RGS proteins on GIRK channel gating (Doupnik et al. 1997; Saitoh et al. 1997; Zerangue & Jan, 1998; Kovoor & Lester, 2002). Incremental increases in Galphaobetagamma coupling by increased Galphao expression revealed a transition in the RGS4-accelerated GIRK currents from 'expected' steady-state properties, characterized by a large reduction in maximal GIRK current amplitude, to 'anomalous' gating kinetics which displayed accelerated activation and deactivation kinetics with no effect on steady-state GIRK amplitude. We propose that this transition in steady-state GIRK channel kinetics is a functional indicator of the formation of a GPCR-G protein-GIRK channel signalling complex (Huang et al. 1995; Slesinger et al. 1995) that is precipitated at a critical level of Galphai/o expression and revealed by the modulatory actions of co-expressed RGS proteins.

RGS proteins reveal GPCR-G protein-GIRK coupling levels via steady-state gating properties

RGS proteins were originally identified as 'negative regulators' of G protein signalling causing reduced GPCR signalling in yeast, fungi, nematodes and mammals (Dohlman et al. 1995, 1996; Druey et al. 1996; Koelle & Horvitz, 1996; Yu et al. 1996). These findings were readily explained by RGS proteins behaving as GTPase-activating proteins and accelerating the termination of G protein signalling (Berman et al. 1996; Chen et al. 1996; Hunt et al. 1996; Watson et al. 1996). Initial studies of the effects of RGS proteins on GPCR-evoked GIRK currents revealed the anticipated acceleration in current deactivation, which was well explained by the RGS-accelerated GTPase activity of Galphai/o subunits causing a more rapid sequesteration of channel-activating Gbetagamma dimers (Doupnik et al. 1997; Saitoh et al. 1997). Unexpectedly, however, the accelerated deactivation was also accompanied with an accelerated activation phase in the absence of reduced current amplitude.

We analysed the temporal and steady-state GIRK current kinetics for the various conditions tested in this study using a simplified two-state gating scheme (Doupnik et al. 1997):

eqt2

where the forward rate constant for GIRK channel opening (kopen) is dependent on the rate of Gbetagamma production during GPCR activation (Breitwieser & Szabo, 1988; Yamada et al. 1998), and the closing rate constant (kclose) is dependent on Gbetagamma clearance, which is rate-limited by the GTP hydrolysis rate of Galpha subunits. Accordingly, the time constant for GIRK channel deactivation (taudeact) is equal to kclose-1, and the time constant for GIRK activation (tauact) is equal to (kopen + kclose)-1 (Doupnik et al. 1997). Using these relations and an empirically derived kopen value of 0.03 s-1 (held constant to simulate a saturating agonist concentration), the experimentally derived taudeact values were used to calculate 'expected' values of tauact and steady-state GIRK current amplitudes (kopen/[kopen + kclose]) in the absence and presence of RGS expression according to the kinetic model. The 'expected' values were then compared to the experimentally 'observed' values (Table 2).

As seen in Table 2, the 'observed' effects of RGS4 on tauact and steady-state amplitude for Galphai-coupled GIRK currents closely correlate with the 'expected' consequences of the RGS4-accelerated deactivation rate, but not so for the Galphao-coupled GIRK currents. Similarly, a correlation was seen for the effects of Gbeta5 on RGS7-accelerated GIRK currents activated by Galphao-coupled receptors. Thus during reduced levels of G protein coupling, GIRK channels behave according to standard kinetic concepts in response to RGS modulation and are consistent with the collision coupling model of G protein activation (Shea & Linderman, 1997; Shea et al. 2000). In contrast, RGS4 and RGS7 modulate Galphao-coupled GIRK currents in a manner similar to previous descriptions of the anomalous kinetic effects of RGS proteins on GIRK channel gating which do not correlate with the kinetic model (Table 2) (Doupnik et al. 1997; Saitoh et al. 1997). We propose that these expression conditions promote the formation of a precoupled m2 receptor-Galphaobetagamma-GIRK channel complex (Huang et al. 1995; Slesinger et al. 1995), having altered activation properties that are revealed by the modulatory effects of RGS proteins and effectively preserve maximal GIRK current amplitudes (see Fig. 8).

F8 View larger version
[in this window]
[in a new window]

Figure 8. RGS modulation of GPCR right GIRK signal transduction at varying levels of G protein coupling

A, collision coupling model (low Galpha expression) and B precoupled model (high Galpha expression). The precoupled model assumes a GPCR-G protein-RGS-GIRK channel complex displaying 'anomalous' kinetic behaviour that was characteristic of oocytes expressing Galphao subunits with either RGS4 or RGS7, together with co-expressed m2 receptors and GIRK channel Kir3.1/3.2a subunits.

GIRK activation kinetics revealed at low levels of basal activity

GIRK channels are composed of four Kir3.0 subunits with each subunit capable of binding a single Gbetagamma dimer, thus a maximum of four Gbetagamma dimers can bind to a single GIRK channel (Corey & Clapham, 2001). Several studies indicate GIRK channel activation is a multi-step process and may represent the binding of multiple Gbetagamma dimers leading to channel opening (Hosoya et al. 1996; Sodickson & Bean, 1996; Nemec et al. 1999). Assuming four bound Gbetagamma dimers promote the channel open state, receptor-independent basal GIRK activity represents channels transiently occupied by four Gbetagamma dimers, excluding the potential influence of phosphatidylinositol-4,5-bisphosphate (PIP2), arachidonic acid, and intracellular Na+, Mg+2 and polyamines (Dascal, 1997; Yamada et al. 1998). IK,basal activity is directly related to the concentration of free Gbetagamma in the cell membrane based on the effectiveness of Gbetagamma scavengers to lower IK,basal amplitudes (Lim et al. 1995; Vivaudou et al. 1997; Jeong & Ikeda, 1999; Fernandez-Fernandez et al. 2001). According to the GIRK channel gating scheme shown in Fig. 4A, basal GIRK activity reflects channels transiently occupied by three to four Gbetagamma dimers where random association of a single free Gbetagamma subunit causes channel opening. Receptor activation of GIRK channels with high free Gbetagamma concentrations predict a single Gbetagamma binding event is necessary to activate the channels and IK,ACh will thus follow a single exponential time course. Conversely, receptor activation with low concentrations of free Gbetagamma predict multiple binding events are necessary for channel opening, producing a sigmoidal IK,ACh time course analogous to the sequential movement of multiple gates during the activation of voltage-gated ion channels (Hodgkin & Huxley, 1952). The observed time course for receptor-dependent GIRK activation at the different levels of basal activity produced by high and low levels of Galphao expression are in agreement with this and similar GIRK gating schemes (Destexhe & Sejnowski, 1995; Hosoya et al. 1996; Ivanova-Nikolova et al. 1998; Yamada et al. 1998). Different levels of GIRK-Gbetagamma occupancy may also influence the voltage-dependent relaxation phenomena associated with RGS4 expression, which is only observed at low agonist concentrations (Inanobe et al. 2001). Although we deliberately express low levels of m2 receptors to slow GIRK activation rates (Herlitze et al. 1999), it should be emphasized that the GIRK activation and deactivation kinetics measured in the oocyte expression system, even with RGS expression, are consistently slower than native mammalian cells and may be limited by solution exchange rates and/or other intrinsic oocyte factors.

Interestingly, overexpression of a PTX-insensitive and RGS-resistant Galphao mutant (GalphaoA(G184S:C351G)) in rat sympathetic neurons also reveals a prominent sigmoidal GIRK activation time course via alpha2-adrenergic receptor activation, and could be dramatically accelerated by coexpression of the N-terminal region of RGS8 (i.e. no RGS domain) (Jeong & Ikeda, 2001). The results of Jeong & Ikeda indicate the RGS8 N-terminal domain facilitates coupling of heterotrimeric GalphaoA(G184S:C351G)betagamma subunits to alpha2-adrenergic receptors, and as a consequence greatly accelerates the GIRK activation time course. Based on our observations of RGS7 reported here, we speculate that N-terminal regions of RGS7 may similarly interact with m2 receptors and facilitate coupling to Galphao in the absence of Gbeta5.

Physiological implications

GIRK channels mediate sIPSPs in the nervous system where the time course and amplitude of inhibitory synaptic events are dependent on the G protein cycle (Luscher et al. 1997). Thus RGS proteins are likely to play an important role in determining the amplitude and temporal properties of GIRK-mediated sIPSPs. Our findings demonstrate GIRK-mediated sIPSPs may be determined by specific GPCR-Galpha-RGS signalling complexes that activate postsynaptic GIRK channels, where certain Galpha-RGS precoupled complexes accelerate GIRK activation and deactivation kinetics without compromising amplitude. Perturbation of these signalling complexes would reduce inhibitory synaptic transmission and promote cellular excitability. The consequences of these events in the mammalian nervous system remain to be elucidated, yet the demonstrated role of RGS complexes in coordinating locomotion and egg laying behaviour in Caenorhabditis elegans highlight their potential impact on mammalian neural signalling (Chase et al. 2001; Robatzek et al. 2001).

  REFERENCES
Top
Abstract
Introduction
Methods
Results
Discussion
References

BERMAN, D. M., WILKIE, T. M. & GILMAN, A. G. (1996). GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86, 445-452 [Medline]
BLAKE, B. L., WING, M. R., ZHOU, J. Y., LEI, Q., HILLMANN, J. R., BEHE, C. I., MORRIS, R. A., HARDEN, T. K., BAYLISS, D. A., MILLER, R. J. & SIDEROVSKI, D. P. (2001). Gbeta association and effector interaction selectivities of the divergent Ggamma subunit Ggamma13. Journal of Biological Chemistry 276, 49267-49274 [Abstract/Full Text]
BREITWIESER, G. E. & SZABO, G. (1988). Mechanism of muscarinic receptor-induced K+ channel activation as revealed by hydrolysis-resistant GTP analogues. Journal of General Physiology 91, 469-494 [Abstract]
BURGON, P. G., LEE, W. L., NIXON, A. B., PERALTA, E. G. & CASEY, P. J. (2001). Phosphorylation and nuclear translocation of a regulator of G protein signaling (RGS10). Journal of Biological Chemistry 276, 32828-32834 [Abstract/Full Text]
CHASE, D. L., PATIKOGLOU, G. A. & KOELLE, M. R. (2001). Two RGS proteins that inhibit Galphao and Galphaq signaling in C. elegans neurons require a Gbeta5-like subunit for function. Current Biology 11, 222-231
CHEN, C.-K., WIELAND, T. & SIMON, M. I. (1996). RGS-r, a retinal specific RGS protein, binds an intermediate conformation of transducin and enhances recycling. Proceedings of the National Academy of Sciences of the USA 93, 12885-12889 [Abstract/Full Text]
COREY, S. & CLAPHAM, D. E. (2001). The stoichiometry of Gbetagamma binding to G-protein-regulated inwardly rectifying K+ channels (GIRKs). Journal of Biological Chemistry 276, 11409-11413 [Abstract/Full Text]
DASCAL, N. (1997). Signalling via the G protein-activated K+ channels. Cellular Signaling 9, 551-573
DASCAL, N., SCHREIBMAYER, W., LIM, N. F., WANG, W., CHAVKIN, C., DIMAGNO, L., LABARCA, C., KIEFFER, B. L., GAVERIAUX-RUFF, C., TROLLINGER, D., LESTER, H. A. & DAVIDSON, N. (1993). Atrial G protein-activated K+ channel: Expression cloning and molecular properties. Proceedings of the National Academy of Sciences of the USA 90, 10235-10239 [Abstract]
DESTEXHE, A. & SEJNOWSKI, T. J. (1995). G protein activation kinetics and spillover of gamma-aminobutyric acid may account for differences between inhibitory responses in the hippocampus and thalamus. Proceedings of the National Academy of Sciences of the USA 92, 9515-9519 [Abstract]
DEVIC, E., PAQUEREAU, L., RIZZOTI, K., MONIER, A., KNIBIEHLER, B. & AUDIGIER, Y. (1996). The mRNA encoding a beta subunit of heterotrimeric GTP-binding proteins is localized to the animal pole of Xenopus laevis oocyte and embryos. Mechanisms of Development 59, 141-151 [Medline]
DE VRIES, L., ZHENG, B., FISCHER, T., ELENKO, E. & FARQUHAR, M. G. (2000). The regulator of G protein signaling family. Annual Review of Pharmacology and Toxicology 40, 235-271 [Abstract/Full Text]
DOHLMAN, H. G., SONG, J. P., MA, D. R., COURCHESNE, W. E. & THORNER, J. (1996). SST2, a negative regulator of pheromone signalling in the yeast Saccharomyces cerevisae - expression, localization, and genetic interaction and physical association with GPA1 (the G-protein alpha-subunit). Molecular and Cellular Biology 16, 5194-5209 [Abstract]
DOHLMAN, H. R., APANIESK, D., CHEN, Y., SONG, J. P. & NUSSKERN, D. (1995). Inhibition of G-protein signaling by dominant gain-of-function mutations in Sst2p, a pheromone desensitization factor in Saccharomyces cerevisae. Molecular and Cellular Biology 15, 3635-3643 [Abstract]
DOUPNIK, C. A., DAVIDSON, N., LESTER, H. A. & KOFUJI, P. (1997). RGS proteins reconstitute the rapid gating kinetics of Gbetagamma-activated inwardly rectifying K+ channels. Proceedings of the National Academy of Sciences of the USA 94, 10461-10466 [Abstract/Full Text]
DRUEY, K. M., BLUMER, K. J., KANG, V. H. & KEHRL, J. H. (1996). Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 379, 742-746 [Medline]
FERNANDEZ-FERNANDEZ, J. M., ABOGADIE, F. C., MILLIGAN, G., DELMAS, P. & BROWN, D. A. (2001). Multiple pertussis toxin-sensitive G-proteins can couple receptors to GIRK channels in rat sympathetic neurons when expressed heterologously, but only native Gi-proteins do so in situ. European Journal of Neuroscience 14, 283-292 [Medline]
FERNANDEZ-FERNANDEZ, J. M., WANAVERBECQ, N., HALLEY, P., CAULFIELD, M. P. & BROWN, D. A. (1999). Selective activation of heterologously expressed G protein-gated K+ channels by M2 muscarinic receptors in rat sympathetic neurones. Journal of Physiology 515, 631-637 [Abstract/Full Text]
GRANNEMAN, J. G., ZHAI, Y., ZHU, Z., BANNON, M. J., BURCHETT, S. A., SCHMIDT, C. J., ANDRADE, R. & COOPER, J. (1998). Molecular characterization of human and rat RGS 9L, a novel splice variant enriched in dopamine target regions, and chromosomal localization of the RGS 9 gene. Molecular Pharmacology 54, 687-694 [Abstract/Full Text]
GREIF, G. J., SODICKSON, D. L., BEAN, B. P., NEER, E. J. & MENDE, U. (2000). Altered regulation of potassium and calcium channels by GABAB and adenosine receptors in hippocampal neurons from mice lacking Galphao. Journal of Neurophysiology 83, 1010-1018 [Abstract/Full Text]
HENRY, D. J., GRANDY, D., LESTER, H. A., DAVIDSON, N., LIM, N. F. & CHAVKIN, C. (1995). kappa opioid receptors couple to inwardly rectifying potassium channels when coexpressed in Xenopus oocytes. Molecular Pharmacology 47, 551-557 [Abstract]
HERLITZE, S., RUPPERSBERG, J. P. & MARK, M. D. (1999). New roles for RGS2, 5 and 8 on the ratio-dependent modulation of recombinant GIRK channels expressed in Xenopus oocytes. Journal of Physiology 517, 341-352 [Abstract/Full Text]
HODGKIN, A. L. & HUXLEY, A. F. (1952). A quantitative description of membrane current and its application to conduction and excitation in nerve. Journal of Physiology 117, 500-544
HOSOYA, Y., YAMADA, M., ITO, H. & KURACHI, Y. (1996). A functional model for G protein activation of the muscarinic K+ channel in guinea pig atrial myocytes. Spectral analysis of the effect of GTP on single-channel kinetics. Journal of General Physiology 108, 485-495 [Abstract]
HUANG, C.-L., SLESINGER, P. A., CASEY, P. J., JAN, Y. N. & JAN, L. Y. (1995). Evidence that direct binding of Gbetagamma to the GIRK1 G protein-gated inwardly rectifying K+ channel is important for channel activation. Neuron 15, 1133-1143 [Medline]
HUNT, T. W., FIELDS